Wendy future of retail top

Gilead Sciences Inc.

Gilead to launch generic versions of its hepatitis drugs

Gilead to launch generic versions of its hepatitis drugs

FOSTER CITY — Gilead Sciences Inc. announced plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare costs. The drugmaker’s generic version of drugs such as harvoni and epclusa, which raked in combined sales of $831 million in the quarter ended

Centrum 7/6  banner